Archived explainer. For the current picture see today's HIMS page.
HIMS & HERS HEALTH I A (HIMS) is down -14.73% in the latest session. Our newswire has captured 11 stories on HIMS across 10 sources in the last 36 hours, with AI sentiment reading bearish (avg 37/100).
Hims & Hers Health Inc (HIMS) fell 14.73% to $25.00 in morning trading as the U.S. Federal Trade Commission filed a lawsuit against the telehealth company. The suit alleges the firm shared sensitive health data with Meta and Snap while misleading users about billing and subscription cancellation practices. The stock has declined 23.5% over the last eight sessions as the legal action intensifies scrutiny of its data and billing practices.
The U.S. Federal Trade Commission filed a federal lawsuit against Hims & Hers, accusing the company of sharing user health data with online advertisers and deceiving customers about billing and subscription cancellation procedures. The lawsuit, announced Wednesday, alleges the telehealth provider violated consumer privacy protections by transferring sensitive health information to third-party platforms such as Meta and Snap. The company responded by stating the lawsuit disregards evidence it provided to the FTC during a nearly three-year investigation. Hims & Hers expressed confidence in its position and pledged to defend itself against the allegations.
The stock has traded within a 52-week range of $13.74 to $70.43 and currently has a market capitalization of $7.0 billion. The company remains unprofitable with a trailing twelve-month earnings per share of -0.06 and a net margin of -0.6%. Revenue grew 32.8% in the trailing twelve months, but the stock’s beta of 2.34 indicates high volatility. Over the last 36 hours, 13 unusual options prints were recorded, with put premiums outpacing call premiums. The largest single options trade involved $2.1 million in premium. In the last 90 days, insiders sold $3.9 million in shares, including multiple sales by CFO Okupe Oluyemi.
The company has not scheduled earnings in the immediate future, but coverage breadth is growing. Retail traders on r/wallstreetbets and social media have mentioned the stock, and options activity remains elevated. The outcome of the FTC lawsuit will be a key factor in shaping investor sentiment.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Not financial advice.
The agency alleges the telehealth company shared sensitive health data with Meta and Snap while deceiving users about charges and cancellations
The U.S. Federal Trade Commission on Wednesday sued the telehealth company over allegations it shared sensitive user health data with advertisers.
The FTC sued Hims & Hers over alleged health data sharing with Meta and Snap, billing practices and subscription cancellations.
Shares in telehealth provider Hims Hers ($HIMS) tumbled about 12% on Wednesday afternoon. This came as the U.S. consumer protection watchdog dragged the compa...
Hims & Hers shared patient health information with Snap and Meta, a federal complaint says.
Hims & Hers (HIMS) stock slips as FTC plans to sue the company over alleged health data sharing with online advertisers including Meta (META). Read more here.
More on HIMS: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier HIMS move explainers: 2026-07-30 · 2026-07-29 · 2026-07-27 · 2026-07-24 · 2026-07-23 · 2026-07-21